Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stem cells stir EC research funding debate:

This article was originally published in Clinica

Executive Summary

The European Research Council has agreed to allow EU funds to be used for embryonic stem cell research, subject to the applicable legislation in the individual member states. The decision, already approved by the European Commission and the European Parliament (see Clinica No 986, p 4), was ratified at last week's meeting to approve the VI Research Framework Programme 2002-06. The ethical issues surrounding stem cell research remain a "particular focus of debate", according to the minutes of the meeting. Other issues included a proposed budget of E2.2 billion ($2.5 billion) for genomics and biotechnology, E1.15 billion for advanced genomics and its healthcare applications, and E1.05 billion to "tackle the principal diseases".

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074405

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel